Compare IDev Technologies vs iScience Interventional

IDev Technologies is 18 yrs old and is based in United States.

IDev Technologies is a medical device company engaged in the development and commercialization of a woven nitinol wire, self expanding stent for treatment of peripheral arterial stenosis. IDEV Technologies' products include SUPERA Veritas, a self-expanding nitinol stent system with CE Mark in Europe for treating blockages in blood vessels due to peripheral artery disease (PAD). Stents are used to prop open a blocked vessel and prevent re-blockage. With its proprietary interwoven wire technology, SUPERA Veritas is designed based on biomimetic principles – attempting to mimic the body's natural movement – to promote blood flow in the treated area while offering strength and flexibility. These properties are particularly important when considering treatment for blockages in the blood vessels in the thigh and knee where rapid and frequent movement occurs with daily activities such as walking, sitting and standing. In August 2013, IDev Technologies was acquired by Abbott Laboratories. The valuation of IDev Technologies was $310 million. Other terms of the deal were not released.